Indole, a core nucleus for potent inhibitors of tubulin polymerization
Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer...
Gespeichert in:
Veröffentlicht in: | Medicinal research reviews 2007-03, Vol.27 (2), p.209-238 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 238 |
---|---|
container_issue | 2 |
container_start_page | 209 |
container_title | Medicinal research reviews |
container_volume | 27 |
creator | Brancale, Andrea Silvestri, Romano |
description | Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev |
doi_str_mv | 10.1002/med.20080 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68969234</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68969234</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</originalsourceid><addsrcrecordid>eNp1kMtOwzAQRS0EgvJY8AMoKyQkQsd2YjtL1JaXeAgBYmnFyUQY0rjYiaB8PYGW7ljNaObcuziE7FM4oQBsOMXyhAEoWCMDCpmKKWVqnQyA9rvgLN0i2yG8AlCaUr5JtqiQSmUKBuTssildjcdRHhXOY9R0RY1diCrno5lrsWkj27xYY1vnQ-SqqO1MV9umf9bzKXr7lbfWNbtko8rrgHvLuUOeziaPo4v4-u78cnR6HRcJkxDLFNAIlZSyrAAZcJaUhiPSfmJJpVHGgMAKFcosyVRuBGNSFFwmPBUV8B1yuOideffeYWj11IYC6zpv0HVBC5WJjPGkB48WYOFdCB4rPfN2mvu5pqB_pOlemv6V1rMHy9LO_FxX5NJSDwwXwIetcf5_k76ZjP8q40XChhY_V4ncv2khuUz18-25fhhf3V-BfNaSfwPSfYUJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68969234</pqid></control><display><type>article</type><title>Indole, a core nucleus for potent inhibitors of tubulin polymerization</title><source>MEDLINE</source><source>Wiley Online Library All Journals</source><creator>Brancale, Andrea ; Silvestri, Romano</creator><creatorcontrib>Brancale, Andrea ; Silvestri, Romano</creatorcontrib><description>Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev</description><identifier>ISSN: 0198-6325</identifier><identifier>EISSN: 1098-1128</identifier><identifier>DOI: 10.1002/med.20080</identifier><identifier>PMID: 16788980</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>anti-mitotic agents ; anti-tumor drugs ; Antimitotic Agents - chemistry ; Antimitotic Agents - pharmacology ; Antineoplastic Agents - chemical synthesis ; Antineoplastic Agents - chemistry ; Antineoplastic Agents - pharmacology ; Biochemistry - methods ; Drug Design ; Humans ; indoles ; Indoles - chemistry ; Nerve Tissue Proteins - chemistry ; Nerve Tissue Proteins - pharmacology ; Structure-Activity Relationship ; tubulin ; Tubulin - drug effects ; Tubulin - metabolism ; Tubulin Modulators</subject><ispartof>Medicinal research reviews, 2007-03, Vol.27 (2), p.209-238</ispartof><rights>Copyright © 2006 Wiley Periodicals, Inc.</rights><rights>(c) 2006 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</citedby><cites>FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmed.20080$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmed.20080$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27923,27924,45573,45574</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16788980$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Brancale, Andrea</creatorcontrib><creatorcontrib>Silvestri, Romano</creatorcontrib><title>Indole, a core nucleus for potent inhibitors of tubulin polymerization</title><title>Medicinal research reviews</title><addtitle>Med. Res. Rev</addtitle><description>Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev</description><subject>anti-mitotic agents</subject><subject>anti-tumor drugs</subject><subject>Antimitotic Agents - chemistry</subject><subject>Antimitotic Agents - pharmacology</subject><subject>Antineoplastic Agents - chemical synthesis</subject><subject>Antineoplastic Agents - chemistry</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Biochemistry - methods</subject><subject>Drug Design</subject><subject>Humans</subject><subject>indoles</subject><subject>Indoles - chemistry</subject><subject>Nerve Tissue Proteins - chemistry</subject><subject>Nerve Tissue Proteins - pharmacology</subject><subject>Structure-Activity Relationship</subject><subject>tubulin</subject><subject>Tubulin - drug effects</subject><subject>Tubulin - metabolism</subject><subject>Tubulin Modulators</subject><issn>0198-6325</issn><issn>1098-1128</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kMtOwzAQRS0EgvJY8AMoKyQkQsd2YjtL1JaXeAgBYmnFyUQY0rjYiaB8PYGW7ljNaObcuziE7FM4oQBsOMXyhAEoWCMDCpmKKWVqnQyA9rvgLN0i2yG8AlCaUr5JtqiQSmUKBuTssildjcdRHhXOY9R0RY1diCrno5lrsWkj27xYY1vnQ-SqqO1MV9umf9bzKXr7lbfWNbtko8rrgHvLuUOeziaPo4v4-u78cnR6HRcJkxDLFNAIlZSyrAAZcJaUhiPSfmJJpVHGgMAKFcosyVRuBGNSFFwmPBUV8B1yuOideffeYWj11IYC6zpv0HVBC5WJjPGkB48WYOFdCB4rPfN2mvu5pqB_pOlemv6V1rMHy9LO_FxX5NJSDwwXwIetcf5_k76ZjP8q40XChhY_V4ncv2khuUz18-25fhhf3V-BfNaSfwPSfYUJ</recordid><startdate>200703</startdate><enddate>200703</enddate><creator>Brancale, Andrea</creator><creator>Silvestri, Romano</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200703</creationdate><title>Indole, a core nucleus for potent inhibitors of tubulin polymerization</title><author>Brancale, Andrea ; Silvestri, Romano</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4270-750eb684d7df0e20324db3ee124ded17b8bb06efe8e79498ab62276c374356f03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>anti-mitotic agents</topic><topic>anti-tumor drugs</topic><topic>Antimitotic Agents - chemistry</topic><topic>Antimitotic Agents - pharmacology</topic><topic>Antineoplastic Agents - chemical synthesis</topic><topic>Antineoplastic Agents - chemistry</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Biochemistry - methods</topic><topic>Drug Design</topic><topic>Humans</topic><topic>indoles</topic><topic>Indoles - chemistry</topic><topic>Nerve Tissue Proteins - chemistry</topic><topic>Nerve Tissue Proteins - pharmacology</topic><topic>Structure-Activity Relationship</topic><topic>tubulin</topic><topic>Tubulin - drug effects</topic><topic>Tubulin - metabolism</topic><topic>Tubulin Modulators</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Brancale, Andrea</creatorcontrib><creatorcontrib>Silvestri, Romano</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Medicinal research reviews</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Brancale, Andrea</au><au>Silvestri, Romano</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Indole, a core nucleus for potent inhibitors of tubulin polymerization</atitle><jtitle>Medicinal research reviews</jtitle><addtitle>Med. Res. Rev</addtitle><date>2007-03</date><risdate>2007</risdate><volume>27</volume><issue>2</issue><spage>209</spage><epage>238</epage><pages>209-238</pages><issn>0198-6325</issn><eissn>1098-1128</eissn><abstract>Microtubules are the basic components of cell structure, which take part in a wide number of pivotal cellular functions. Drugs that are able to modulate the microtubule assembly either by inhibition of tubulin polymerization or by blocking microtubule disassembly are of great interest in anti‐cancer therapy. Several tubulin polymerization inhibitors characterized by the presence of an indole nucleus have been obtained from natural sources or have been prepared by semi‐synthesis. In the last decade an ever increasing number of synthetic indoles have been reported. We have reviewed anti‐tubulin agents obtained by synthesis having an indole as core nucleus. The synthesis, the biological activity, and the structure–activity relationship aspects of 3‐formyl‐2‐phenylindoles, heterocombretastatins, diarylindoles, 2‐aroylindoles, D‐24851, 2‐aryl‐3‐aroylindoles, 3‐aroyl‐ and 1‐aroylindoles, and arylthioindoles are discussed. © 2006 Wiley Periodicals, Inc. Med Res Rev</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>16788980</pmid><doi>10.1002/med.20080</doi><tpages>30</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0198-6325 |
ispartof | Medicinal research reviews, 2007-03, Vol.27 (2), p.209-238 |
issn | 0198-6325 1098-1128 |
language | eng |
recordid | cdi_proquest_miscellaneous_68969234 |
source | MEDLINE; Wiley Online Library All Journals |
subjects | anti-mitotic agents anti-tumor drugs Antimitotic Agents - chemistry Antimitotic Agents - pharmacology Antineoplastic Agents - chemical synthesis Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Biochemistry - methods Drug Design Humans indoles Indoles - chemistry Nerve Tissue Proteins - chemistry Nerve Tissue Proteins - pharmacology Structure-Activity Relationship tubulin Tubulin - drug effects Tubulin - metabolism Tubulin Modulators |
title | Indole, a core nucleus for potent inhibitors of tubulin polymerization |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T20%3A35%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Indole,%20a%20core%20nucleus%20for%20potent%20inhibitors%20of%20tubulin%20polymerization&rft.jtitle=Medicinal%20research%20reviews&rft.au=Brancale,%20Andrea&rft.date=2007-03&rft.volume=27&rft.issue=2&rft.spage=209&rft.epage=238&rft.pages=209-238&rft.issn=0198-6325&rft.eissn=1098-1128&rft_id=info:doi/10.1002/med.20080&rft_dat=%3Cproquest_cross%3E68969234%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68969234&rft_id=info:pmid/16788980&rfr_iscdi=true |